PEPTIDE VACCINE COMPRISING MUTANT RAS PEPTIDE AND CHEMOTHERAPEUTIC AGENT

• 收藏
• 分享

专利权人:

Targovax ASA

发明人:

Jon Amund Eriksen,Gustav Gaudernack

申请号：

US15308917

公开号：

US20170065694A1

申请日:

2015.05.05

申请国别(地区):

US

年份:

2017

代理人:

摘要：

There is disclosed at least one peptide suitable for eliciting an immune response, for use in the treatment of cancer. The, or each, peptide corresponds to a fragment of the RAS protein, but has one to three point mutations thereof. The at least one peptide is for use in the treatment of cancer by simultaneous or sequential administration with an anti-metabolite chemotherapeutic agent.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/